Publications by authors named "Luke Zangl"

Claim this Profile
T
The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor Efficacy.
Caroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski, David P Adam, Thanh Phuong T Nguyen, Luke M Zangl

Cancer Immunol Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of clinically relevant radionuclides on the activation of a type I interferon response by radiopharmaceuticals in syngeneic murine tumor models.
Caroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski, David P Adam, Thanh Phuong T Nguyen, Luke M Zangl

bioRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATM inhibition augments type I interferon response and antitumor T-cell immunity when combined with radiation therapy in murine tumor models.
Won Jong Jin, Luke M Zangl, Meredith Hyun, Elian Massoud, Kaleb Schroeder

J Immunother Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation Augments the Local Anti-Tumor Effect of Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor Models.
Alexander A Pieper, Luke M Zangl, Dan V Speigelman, Arika S Feils, Anna Hoefges

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy.
Justin C Jagodinsky, Won Jong Jin, Amber M Bates, Reinier Hernandez, Joseph J Grudzinski, Luke M Zangl

Theranostics· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Bempegaldesleukin and Anti-CTLA-4 Prevents Metastatic Dissemination After Primary Resection or Radiotherapy in a Preclinical Model of Non-Small Cell Lung Cancer.
Amber M Bates, Ryan J Brown, Alexander A Pieper, Luke M Zangl, Ian Arthur

Front Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial-Membrane-Coated Nanoparticles.
Ravi B Patel, Mingzhou Ye, Peter M Carlson, Abigail Jaquish, Luke Zangl

Adv Mater· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis